II MEDICINE CLINIC

An approach to tinnitus management
o kHz and continuing through to 8 kHz; the decrease was slightly greater in the right ear.
Speech reception was normal in quiet, but there was a significant drop in discrimination in the right ear during simulated background noise (figure 1). Tympanometry was normal in both ears. Acoustic stapedial reflexes were absent with contralateral stimulation in the left ear at 0.5 and 4 kHz, and they elicited a response indicating a chochlear site in the right ear at 4 kHz. There was no stapedial reflex decay. Otoacoustic emissions-both transient-evoked and distortionproduct-were present in both ears, less so in the right (figure 2).
Electronystagmography was negati ve for spontane-A 46-year-old man presented with a 4-month history of tinnitus. Six months earlier, he had experienced a dental infection. Two months later, he noticed the tinnitus one day upon awakening. He also noticed bifrontal pressure in his head that extended across the temporal area and a feeling of dizziness with associated nausea. He remained in bed for the rest of that day, and when he awoke the next morning, his symptoms were completely gone.
A day or two later, the patient experienced a recurrence of all symptoms except dizziness. He also noticed some aural fullness and hypersensitivity to sound. He was treated with a variety of agents, including selenium, magnesium, ginkgo biloba, and flavonoids. These agents seemed to provide some degree of improvement, but it was not sustained. He was next placed on a diuretic and later switched to a corticosteroid and then to alprazolam, but these drugs provided only temporary relief.
Eventually, the patient was referred to the author. He reported that at times his symptoms would completely disappear. His hyperacusis seemed to have diminished during the month prior to presentation. He had no subjective hearing loss. When present, the degree of aural fullness and tinnitus was about equal on both sides. His current medications included alprazolam, eszopiclone, and hydrochlorothiazide. His family history was positive for hearing loss. He was a nonsmoker, had stopped drinking alcohol upon the onset of symptoms, and had been on a low-salt diet for 3 months.
The neurotologic examination revealed an anxious and hyperactive patient who had minimal to mild difficulty performing the sharpened tandem Romberg test. Physical examination revealed occipital muscle tenderness and spasm on the left.
Audiology demonstrated normal hearing in both ears to 2 kHz and a moderate dropoff beginning at 3 From Neurotologic Associates, PC, New York City (Dr. Brookler), and th e Cleveland Hearing and Balance Center, Beachwood, Ohio (Dr. Hamid).
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Exam Cho ir AUDITORY AND VESTIB ULAR MEDICIN E C LINIC LEFT EAR BASELINE qu encies-findings that are consistent with a per ipheral vestibular disorder. Symmetry was normal and consistent with the patient's lack of vestibu lar symptoms . Fixation suppression was present throughout calor ic and rotatory testing.
The salient laboratory findings were abno rmalities on the glucose tolerance test and a deficiency of vitamin D.
RIGHT EAR -1 ous, positional, neck torsion, and vertical nystagmus. Calor ic stimulation with the closed-loo p caloric irrigator was admin-0. !!2. istered with the al-!eJ tern ate binaural bithermal (ABB) and the sim ultaneous binaural bit hermal (SBB) tests. TheABB test showed a 31% reduced vestibular Figure 2 . Baseline distortion-product otoacoustic emissions.
response right and a 69% directional preponderance to the right . The SBB test elicited a type 3 response with a right-beating nystagm us produced with either of th e bith ermal stim uli; the latter is compatible with the directional preponderance to the right on the ABB test.
The sinusoidal vertical-axis rota tion test revealed normal gains and a lag or borderline lag at three fre- The serum glucose levels fluctuated normally for the first 2 hours, but then they fell from 119 mg/dl at the second hour to 49 mg/d l at the third hour. Simultaneous insulin levels were elevated according to the criteria established by Kraft.' The 25-hydroxy vitamin D level on liquid chromatography was 20.8 ng/ml (normal: 32 to 100).
Overlapping thin-section (0.6 mm) axial and coronal computed tomography (CT) of the temporal bone s was obtained. The basal turn of the cochlea contained a mixed sclerotic and spongiotic plaque in the right ear from the base at the footplate to the apex and a sclerotic plaque in the left ear from the base at the posterior interna l auditory canal to the apex. These findings were consistent with inner ear otosclerosis. The patient was placed on a diet to address his serum glucose and insulin findin gs. To address the otosclerosis, he was placed on risedronate 30 mg twice weekly plus daily supplementation with calcium/vitam in D, vitamin D 3 , and fluoride .
At follow-up 3 months later, the patient said his tinnit us had become less intense and remained intermittent. When present, it lasted 2 or 3 days. The hyperacu-sis, headaches, and neck pain were present only when the tinnitus was. He had experienced no dizziness but did feel a wave of weakness and heavine ss in his head for 24 hour s when he would try to focus his eyes. The aural fullness had disappeared after the first week of treatment.
Repeat audiometry revealed similar pure tones and speech findin gs, and an improvement in noise in the right ear only to 80%. Oto acoustic emissions testin g revealed similar transient-evoked findin gs and an increase in the range of th e distortion-product findings in the right ear. The 25-hydroxy vitamin D level was now norm al. Etidronate 400 mg daily for 2 of every 6 weeks was added to th e pat ient's continued medical regimen; risedronate was discontinued during the 2-week periods on etidronate.
At another follow-up visit 3 months later, the patient said he had initially experienced no change in th e severity, number, or duration of his tinnitus episode s, and the hyperacusis was not as bad as it had been. He continued to have some difficulty hearing in background noise. The aura l fullness had not'returned, but LEFT EAR C!l "0 same as before, and speech discrimination in no ise impro ved to 92% in the right ear and 84% in the left ear. Otoacoustic emissions testing revealed improvement in both tr ansient-evoked and distortion -product findings in both ears (figure 3). Treatment was continued with th e etidronate for 2 of every 13 weeks. Thi s case brings up several discussion points. Based on a minimal history of vestibular symptoms, the find ings of a per iph eral vestibular disorder on electronystagmography and no abnorma l symmetry on sinusoidal vertical-axis rotation testing indicate a lon gstand ing inner ear disorder. With a pre -existing inner ear disorder, a dental infection 2 months before the onset of symptoms (significant enough for the patient to includ e in his history) could have acted as an inflammatory stim ulus for the subse quent find ings. The fact that his symptoms abated spo nta neo usly and briefly suggests an element of reversibility. The presence of head pressure with tinn itus and hyperacusis is consistent with the activation of the vestibilucollic reflex that produced the occipital muscle spasm.
While the tinnitus did not localize to one ear or one side of the head, th ree finding s po int to a predominantl y right-sided lesion : speech discrimination in noise, the result s of ABB electronystagmography, and th e distortion-product oto acoustic emis sions.
Thin-slice CT of the temp oral bones revealed cochlear capsule lesion s con sistent with those seen in otosclerosis. The laboratory evaluation sho wed a vitamin D deficiency th at readily responded to supplemental vitamin D3' The patient's serum glucose level fluctuated significantly and his insulin level was also sufficiently elevated to adversely affect inner ear function.
Treatm ent directed at the otosclerosis and diet directed at the metabolic factors initially resulted in periods when th e absence of symptoms was more beginning with the second cycle of etidronate, the tinnitus intensified for 11 of the next 30 days; this was accompanied by an off-balance feeling. Again, the headaches and neck pain para lleled the tinnitus.
Audiometry revealed an imp rovement in the pure tones in bo th ears at the higher frequencies. Speech testing was similar in quiet with a reduction in discrimination in no ise to 68% in both ears. His tinnitus was matched in both ears at 3.6 to 3.7 kH z in both ears at the limit of the electrical audiometer and could not be suppressed with continued electric al stimulation. Transient-evoked otoacoustic emission s were less than th ey had been at th e pr eviou s visit. The distortionproduct emis sions were present in both ears-more so on the left-and they were improved over the previous test only on the left.
The treatment regimen was chan ged so th at etidronate was taken for 2 of every 8 weeks. Because the tinnitus increased with etidronate use, the patient insisted on another contrast-enhanced MRI despite counseling against it; the MRI was negative. Followup laboratory testing identified a marked increase in his seru m glucose and insulin levels. On furt her questioning, the patient admitted that he had enlarged the portions of the nutritionally acceptable foods he ate because he had been losing weight on his diet. He was encouraged to return to the original diet.
Four months later, the patient volunteered that for 7 days in a row, his tinnitus had stopped by 9 a.m ., but 2 1 / 2 weeks before this visit, th e tinnitus had returned and had persisted until th e day before . It was worse than it had been during his follow-up visits, but not as bad as it had been at the onse t of his original symptoms approximately 10 months earlier. The hyperacusis and headaches continued to parallel the tinnitus, but the neck stiffness had abated somewhat. He stili had not experienced any recurrence of his aura l fullness or dizziness .
Follow-up blood testing demonstrated a continuing elevation in the pat ient 's serum insulin level. Puretone audio me try and speech in quiet remained the common th an their presence and when the overall inten sity of th e tinnitus was less. But th en th e addition of a nonamine bispho sphonate (etidronate) to an aminecontaining bisph osphon ate (risedro nate) initi ally intensified th e symptoms. This effect, which has been reported by others as an ind icator of the drug's effect on the inner ear, paradoxically resulted in subsequent improvement. After 7 months on the bisphosphonate combination, the patient was already experiencing lon ger symptom-free period s. Follow-u p glucose tolerance testing after he had begun to eat more revealed seru m glucose levels consist ent with a diagno sis of diabetes and an elevation in serum insulin to levels much higher than they had been at the outset. These finding s suggest th at his metabolic condition was evolving into th e insulin resistance syndro me and ultimately to type 2 diabetes. The use of otoa coustic emissions testing in th e diagnosis and monitoring of the respon se to treatment is helpful in the management of ·the tinnitus patient. It is widely held th at dyssynchrony in th e output of th e auditory periphery is a basis for th e symptoms of tinnitus. In thi s case, the dyssynchrony was demonstrated with distortion products before tr eatm ent. While th ese distortion product results 10 mo nths into treatm ent indi cated no overwhelmin g improvement , th ey did indicate at least some improvement , especially in th e previously more abnormal right ear.
Extern al sound devices have enjoyed some popularity and success in the tr eatment of tinnitus. But th ey address tinnitus only by possibly reorga nizing the dyssynchrony; they do not add ress th e underlying etiology.The symptom of tinnitus could herald a progre ssive hearing loss or a severe vestibu lar disorder that might be avoided if the underlying etiology could be found and treated. Such a development might also result in a perm anent cure of tinnitus. 
